YU36188B - Process for obtaining therapeutically active complex inosine compounds and salts thereof - Google Patents

Process for obtaining therapeutically active complex inosine compounds and salts thereof

Info

Publication number
YU36188B
YU36188B YU2145/70A YU214570A YU36188B YU 36188 B YU36188 B YU 36188B YU 2145/70 A YU2145/70 A YU 2145/70A YU 214570 A YU214570 A YU 214570A YU 36188 B YU36188 B YU 36188B
Authority
YU
Yugoslavia
Prior art keywords
salts
therapeutically active
active complex
obtaining therapeutically
inosine compounds
Prior art date
Application number
YU2145/70A
Other languages
English (en)
Other versions
YU214570A (en
Inventor
Gordon Paul
Paul Gordon
Original Assignee
Newport Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals filed Critical Newport Pharmaceuticals
Publication of YU214570A publication Critical patent/YU214570A/xx
Publication of YU36188B publication Critical patent/YU36188B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU2145/70A 1969-08-28 1970-08-25 Process for obtaining therapeutically active complex inosine compounds and salts thereof YU36188B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85386469A 1969-08-28 1969-08-28

Publications (2)

Publication Number Publication Date
YU214570A YU214570A (en) 1981-04-30
YU36188B true YU36188B (en) 1982-02-25

Family

ID=25317098

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2145/70A YU36188B (en) 1969-08-28 1970-08-25 Process for obtaining therapeutically active complex inosine compounds and salts thereof

Country Status (24)

Country Link
US (1) US3646007A (xx)
JP (2) JPS493999B1 (xx)
AT (1) AT299457B (xx)
BE (1) BE755361A (xx)
BR (1) BR6915483D0 (xx)
CA (1) CA920125A (xx)
CH (1) CH530998A (xx)
CS (1) CS183616B2 (xx)
DE (2) DE1965431C3 (xx)
DK (1) DK137801B (xx)
ES (1) ES375387A1 (xx)
FR (1) FR2068522B1 (xx)
GB (1) GB1252401A (xx)
HU (1) HU162297B (xx)
IL (1) IL35135A (xx)
LU (1) LU61603A1 (xx)
NL (1) NL140735B (xx)
NO (1) NO126800B (xx)
PH (2) PH9221A (xx)
PL (1) PL80960B1 (xx)
SE (1) SE384866B (xx)
SU (1) SU381216A3 (xx)
YU (1) YU36188B (xx)
ZA (1) ZA705913B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2260331B1 (xx) * 1974-02-08 1978-01-13 Mauvernay Centre Europ Rech
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4387226A (en) * 1981-08-26 1983-06-07 Newport Pharmaceuticals International, Inc. Purine-dihydrothiazoles
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
JPS5994567U (ja) * 1982-12-15 1984-06-27 松下電工株式会社 折り畳みドアのラツチ構造
US4512981A (en) * 1982-12-20 1985-04-23 Newport Pharmaceuticals International, Inc. Method of treating inflammation using inosiplex
DE3404315C1 (de) * 1984-02-08 1985-05-09 Newport AG, Zug Verwendung von Inosin-haltigen Wirkstoffen zur Wachstumsfoerderung bei der Mast von Nutztieren
FR2652003A1 (fr) * 1989-09-20 1991-03-22 Delalande Sa Utilisation d'un complexe de l'inosine avec un n,n-dialkylamino alcanol ou un sel de celui-ci avec un acide pharmacologiquement acceptable pour le traitement de certaines infections helminthiques.
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104744541A (zh) * 2014-05-05 2015-07-01 深圳信立泰药业股份有限公司 一种异丙肌苷新晶型、其制备方法及含有该新晶型的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB879259A (en) * 1956-11-20 1961-10-11 Riker Laboratories Inc Acid addition salts of 2-dimethylaminoethanol and central nervous system stimulant compositions containing them
US3438968A (en) * 1966-06-23 1969-04-15 Int Chem & Nuclear Corp Substituted ammonium basic addition salts of ribonucleic acid

Also Published As

Publication number Publication date
NL7000574A (xx) 1971-03-02
IL35135A (en) 1974-07-31
BR6915483D0 (pt) 1973-03-13
GB1252401A (xx) 1971-11-03
PH9221A (en) 1975-07-10
DE1967073A1 (de) 1976-12-02
US3646007A (en) 1972-02-29
DE1965431A1 (de) 1971-04-08
SE384866B (sv) 1976-05-24
JPS4921765B1 (xx) 1974-06-04
JPS493999B1 (xx) 1974-01-29
FR2068522B1 (xx) 1974-08-30
BE755361A (fr) 1971-03-01
DE1965431B2 (de) 1978-05-18
AT299457B (de) 1972-06-26
DK137801C (xx) 1978-10-16
SU381216A3 (xx) 1973-05-15
CH530998A (de) 1972-11-30
CS183616B2 (en) 1978-07-31
LU61603A1 (xx) 1971-08-05
HU162297B (xx) 1973-01-29
DK137801B (da) 1978-05-08
FR2068522A1 (xx) 1971-08-27
DE1965431C3 (de) 1979-01-04
IL35135A0 (en) 1970-10-30
PL80960B1 (en) 1975-08-30
PH10011A (en) 1976-07-13
ZA705913B (en) 1971-04-28
NL140735B (nl) 1974-01-15
YU214570A (en) 1981-04-30
DE1967073C2 (de) 1986-04-17
CA920125A (en) 1973-01-30
ES375387A1 (es) 1972-05-01
NO126800B (xx) 1973-03-26

Similar Documents

Publication Publication Date Title
MTP666B (en) Pyrazinamide derivatives and processes for their preparation
YU99470A (en) Process for obtaining cephalexin monohydrate
YU36188B (en) Process for obtaining therapeutically active complex inosine compounds and salts thereof
YU238570A (en) Process for obtaining amino-alshols
YU216571A (en) Process for obtaining 4-oxo-4h-1-benzopyran derivatives
IL35847A (en) Evomonoside derivatives and process for the preparation thereof
IL34479A0 (en) Novel therapeutically active benzothiazine derivatives and process for their preparation
ZA705118B (en) New basic compounds and process for their preparation
IL31513A0 (en) Phenethylamine derivatives and process for the manufacture thereof
IL35870A (en) Neriifolin derivatives and process for their preparation
ZA713618B (en) Benzenesulfonyl-urea derivatives and process for their manufacture
ZA711739B (en) Fluoralkyl-sulfur compounds and process for their manufacture
YU201378A (en) Process for obtaining 3-amino-delta2-pyrazoline
IL36235A0 (en) Novel therapeutically active substituted phenoxyethylamines and process for their preparation
ZA711335B (en) Phamracologically active aminoalcohols and process for their production
IL33788A0 (en) Pharmaceutically active thiachromone derivatives
IL35684A0 (en) Thiosemicarbazone derivatives and process for their preparation
ZA714360B (en) New heterocyclic compounds and process for their manufacture
IL36248A0 (en) Novel therapeutically active dihydrobenzothiazine-s-dioxides and process for their preparation
IL34129A (en) Process for the preparation of methyl p-aminobenzenesulphonyl-carbamate
YU35432B (en) Process for obtaining optically active bicycloalkane derivatives
ZM15969A1 (en) Pharmaceutically active compounds
IL34209A0 (en) Alpha-methylbiotin and process for its preparation
IL30479A0 (en) Process for the preparation of new therapeutically active 5-nitro-furfural hydrazones
AU422443B2 (en) New therapeutically active substituted phenoxy-ethylamines and process for their preparation